CA2419471C - Use of triazinetrione sulphones for controlling coccidioses - Google Patents

Use of triazinetrione sulphones for controlling coccidioses Download PDF

Info

Publication number
CA2419471C
CA2419471C CA002419471A CA2419471A CA2419471C CA 2419471 C CA2419471 C CA 2419471C CA 002419471 A CA002419471 A CA 002419471A CA 2419471 A CA2419471 A CA 2419471A CA 2419471 C CA2419471 C CA 2419471C
Authority
CA
Canada
Prior art keywords
weight
concentration
formula
suspension
ponazuril
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002419471A
Other languages
English (en)
French (fr)
Other versions
CA2419471A1 (en
Inventor
Gisela Greif
Iris Heep
Hans-Christian Mundt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Intellectual Property GmbH
Original Assignee
Bayer Animal Health GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health GmbH filed Critical Bayer Animal Health GmbH
Publication of CA2419471A1 publication Critical patent/CA2419471A1/en
Application granted granted Critical
Publication of CA2419471C publication Critical patent/CA2419471C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/30—Only oxygen atoms
    • C07D251/34—Cyanuric or isocyanuric esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002419471A 2000-08-17 2001-08-06 Use of triazinetrione sulphones for controlling coccidioses Expired - Lifetime CA2419471C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10040174A DE10040174A1 (de) 2000-08-17 2000-08-17 Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10040174.0 2000-08-17
PCT/EP2001/009060 WO2002014288A1 (de) 2000-08-17 2001-08-06 Verwendung von triazintrion-sulfonen zur bekämpfung von coccidiosen

Publications (2)

Publication Number Publication Date
CA2419471A1 CA2419471A1 (en) 2003-02-14
CA2419471C true CA2419471C (en) 2009-10-13

Family

ID=7652719

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002419471A Expired - Lifetime CA2419471C (en) 2000-08-17 2001-08-06 Use of triazinetrione sulphones for controlling coccidioses

Country Status (23)

Country Link
US (1) US7915257B2 (enExample)
EP (1) EP1311491A1 (enExample)
JP (1) JP2004506624A (enExample)
KR (1) KR100803078B1 (enExample)
CN (3) CN101361743A (enExample)
AR (1) AR030378A1 (enExample)
AU (2) AU2001278522B2 (enExample)
BR (1) BR0113268A (enExample)
CA (1) CA2419471C (enExample)
CZ (1) CZ300020B6 (enExample)
DE (1) DE10040174A1 (enExample)
HR (1) HRP20030194A2 (enExample)
HU (1) HUP0303701A3 (enExample)
MX (1) MXPA03001429A (enExample)
MY (1) MY136518A (enExample)
NO (1) NO20030585D0 (enExample)
NZ (1) NZ524200A (enExample)
PL (1) PL359709A1 (enExample)
SK (1) SK1652003A3 (enExample)
TW (1) TW200819431A (enExample)
WO (1) WO2002014288A1 (enExample)
YU (1) YU11703A (enExample)
ZA (1) ZA200301225B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
SI22751A (sl) 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP2740469A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740470A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
CN102973497A (zh) * 2012-12-13 2013-03-20 江苏恒丰强生物技术有限公司 一种托曲珠利溶液及其制备方法
US11352332B2 (en) 2018-02-26 2022-06-07 AlzeCure Pharma AB Triazine derivatives for treating diseases relating to neurotrophins
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds
JP7825401B2 (ja) * 2021-09-30 2026-03-06 株式会社ジーシーR&D 主材ペースト、及び歯科用アルギン酸塩印象材

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413722C3 (de) 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel
DE2414612A1 (de) 1974-03-26 1975-10-16 Bayer Ag 1-aryluracile, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2532363A1 (de) 1975-07-19 1977-02-03 Bayer Ag Substituierte 2-phenyl-1,2,4- triazin-3,5(2h,4h)-dione, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4255231A (en) * 1979-06-13 1981-03-10 Congoleum Corporation Carpet etching
DE3314739A1 (de) * 1983-04-23 1984-10-25 Bayer Ag, 5090 Leverkusen 1-(4-(4-(fluoralkylmethylthio- oder -sulfinyl- oder -sulfonyl-)phenoxy) phenyl)-1,3,5-triazin-2,4,6(1h,3h,5h)-trione, verfahren zu ihrer herstellung und ihre verwendung als coccidiosemittel
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
US4808404A (en) * 1988-01-11 1989-02-28 A. H. Robins Company, Inc. Live vaccine for coccidiosis utilizing coccidial sporozoites
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
HK1043019B (zh) 1998-10-08 2005-05-13 高新研究公司 用於预防和治疗原虫病的组合物和方法
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
HUP0104716A3 (en) * 1998-12-22 2003-10-28 Bayer Corp Pittsburgh Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing them

Also Published As

Publication number Publication date
US7915257B2 (en) 2011-03-29
KR100803078B1 (ko) 2008-02-18
AU2001278522B9 (en) 2002-02-25
KR20030017659A (ko) 2003-03-03
NZ524200A (en) 2005-02-25
YU11703A (sh) 2006-01-16
US20040013699A1 (en) 2004-01-22
NO20030585L (no) 2003-02-06
DE10040174A1 (de) 2002-02-28
MY136518A (en) 2008-10-31
CZ300020B6 (cs) 2009-01-14
CN101361743A (zh) 2009-02-11
HUP0303701A3 (en) 2006-01-30
SK1652003A3 (en) 2004-02-03
PL359709A1 (en) 2004-09-06
AU2001278522B2 (en) 2007-03-22
EP1311491A1 (de) 2003-05-21
CA2419471A1 (en) 2003-02-14
ZA200301225B (en) 2004-02-16
HRP20030194A2 (en) 2005-10-31
CN1853635A (zh) 2006-11-01
BR0113268A (pt) 2003-07-08
NO20030585D0 (no) 2003-02-06
MXPA03001429A (es) 2004-05-04
CN1469868A (zh) 2004-01-21
AU7852201A (en) 2002-02-25
WO2002014288A1 (de) 2002-02-21
TW200819431A (en) 2008-05-01
JP2004506624A (ja) 2004-03-04
HUP0303701A2 (hu) 2004-03-29
AR030378A1 (es) 2003-08-20

Similar Documents

Publication Publication Date Title
CA2660762C (en) Transdermal application of triazines for controlling infections with coccidia
US7915257B2 (en) Use of triazinetrione sulfones for combating coccidiosis
NO320712B1 (no) Blandinger av substituerte benzimidazoler og anvendelse derav
US20030181451A1 (en) Use of triazinetrione sulfoxides for controlling coccidioses
US6620833B1 (en) Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas
US20070232609A1 (en) Novel Antiparasitic Combination of Active Compounds
CA2250507A1 (en) Use of substituted aryl imidazoles
CA2222517C (en) Agents for use against parasitic protozoa
CA2111146A1 (en) Use of cn-substituted benzimidazoles
HK1127299A (en) Use of triazinetrione sulphone for controlling coccidioses
MXPA97009187A (en) Agents against parasi protocols

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20210806